We are live on
!
Find out more
OAM
Oberweis Asset Management Portfolio holdings
AUM
$3.39B
1-Year Est. Return
105.5%
This Fund
S&P 500
This Quarter
Est. Return
+20.43%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$645M
AUM Growth
+$174M
(+37%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
15.81%
Top 10 Holdings %
Top 10 Hldgs %
34.62%
Holding
192
New
24
Increased
127
Reduced
13
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$5.59M |
| 2 |
Perion Network
PERI
|
+$4.65M |
| 3 |
Impinj
PI
|
+$4.54M |
| 4 |
Treace Medical Concepts
TMCI
|
+$3.62M |
| 5 |
AYX
Alteryx Inc
AYX
|
+$3.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Super Micro Computer
SMCI
|
+$9.95M |
| 2 |
Clearfield
CLFD
|
+$8.9M |
| 3 |
Constellium
CSTM
|
+$5.61M |
| 4 |
Ameresco
AMRC
|
+$4.93M |
| 5 |
Titan International
TWI
|
+$3.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.71% |
| 2 | Healthcare | 15.75% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Materials | 13.2% |
| 5 | Industrials | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Constellium
CSTM
$3.96B
| $69.6M | 10.8% |
4,553,786
-385,526
| -8% | -$5.61M |
|
2
Axcelis
ACLS
$4.12B
| $36.2M | 5.62% |
271,989
-7,560
| -3% | -$888K |
|
3
Aehr Test Systems
AEHR
$2.48B
| $21.7M | 3.36% |
699,108
+91,500
| +15% | +$2.95M |
|
|
4
Impinj
PI
$3.89B
| $19.8M | 3.08% |
146,275
+35,610
| +32% | +$4.54M |
|
|
5
Perion Network
PERI
$367M
| $15.3M | 2.38% |
387,170
+139,770
| +56% | +$4.65M |
|
6
Lantheus
LNTH
$6.82B
| $14.7M | 2.29% |
178,540
+13,600
| +8% | +$877K |
|
7
Crocs
CROX
$6.69B
| $13.3M | 2.07% |
105,350
+1,300
| +1% | +$157K |
|
8
Deckers Outdoor
DECK
$13.3B
| $12.7M | 1.97% |
169,680
+6,960
| +4% | +$486K |
|
9
Alphatec Holdings
ATEC
$1.27B
| $10.6M | 1.64% |
678,530
+175,240
| +35% | +$2.48M |
|
|
VRTV
10
DELISTED
VERITIV CORPORATION
VRTV
| $9.12M | 1.42% |
67,490
+5,348
| +9% | +$685K |
|
11
Transmedics
TMDX
$2.5B
| $8.2M | 1.27% |
108,300
+25,900
| +31% | +$1.79M |
|
12
Belden
BDC
$4B
| $8.04M | 1.25% |
92,672
+903
| +1% | +$74.9K |
|
13
Clean Harbors
CLH
$16.1B
| $7.25M | 1.12% |
50,835
+2,500
| +5% | +$326K |
|
14
ICF International
ICFI
$1.44B
| $6.95M | 1.08% |
63,400
+20,000
| +46% | +$2.08M |
|
15
Amphastar Pharmaceuticals
AMPH
$825M
| $6.68M | 1.04% |
178,200
+44,200
| +33% | +$1.45M |
|
16
OneSpan
OSPN
$562M
| $6.32M | 0.98% |
361,300
+144,400
| +67% | +$2.16M |
|
17
Halozyme
HALO
$9.72B
| $6.26M | 0.97% |
164,040
+20,650
| +14% | +$969K |
|
18
Ciena
CIEN
$55.3B
| $6.21M | 0.96% |
118,305
+37,920
| +47% | +$1.89M |
|
19
Visteon
VC
$2.77B
| $6.18M | 0.96% |
39,400
+17,000
| +76% | +$2.63M |
|
20
Allegro MicroSystems
ALGM
$8.58B
| $5.93M | 0.92% |
123,500
+8,300
| +7% | +$338K |
|
21
Evolent Health
EVH
$475M
| $5.44M | 0.84% |
167,710
+28,370
| +20% | +$897K |
|
|
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.22M | 0.81% |
+95,740
| New | +$5.59M |
|
|
EVRI
23
DELISTED
Everi Holdings
EVRI
| $5.17M | 0.8% |
301,300
+76,500
| +34% | +$1.32M |
|
24
United Parks & Resorts
PRKS
$2.11B
| $4.95M | 0.77% |
80,800
+23,600
| +41% | +$1.44M |
|
25
MaxLinear
MXL
$6.49B
| $4.95M | 0.77% |
140,460
+27,000
| +24% | +$978K |
|
Similar funds
BG
DFO
VFCM
BCM
MCM
EFM
DIA
5NCM
Oberweis Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Oberweis Asset Management held 192 positions worth $645M, up 37% from $470M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Oberweis Asset Management deployed $102M of net new capital in Q1 2023, opening 24 new positions and adding to 127 existing holdings. Its largest new stake was Axonics, Inc. Common Stock: 95,740 shares worth $5.22M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Constellium, an estimated $5.61M trimmed.
- Oberweis Asset Management's largest Q1 2023 buy was Axonics, Inc. Common Stock: 95,740 shares worth $5.22M.
- Oberweis Asset Management added most to Perion Network in Q1 2023, an estimated $4.65M increase.
- Oberweis Asset Management's biggest Q1 2023 reduction was Constellium, cutting an estimated $5.61M.
- Oberweis Asset Management fully exited Super Micro Computer in Q1 2023, selling an estimated $9.95M.
- Oberweis Asset Management's ten largest holdings make up 35% of its $645M portfolio in Q1 2023.
- Oberweis Asset Management opened 24 new positions and closed 18 in Q1 2023.
- Oberweis Asset Management's portfolio value rose 37% quarter-over-quarter to $645M.
Based on Oberweis Asset Management's 13F filing for Q1 2023, filed 15 May 2023.